Our advanced diagnostic imaging services are performed at North Valley Advanced Imaging. Located on the corner of Esplanade and E. Seventh Avenue, our center offers conventional high-resolution Magnetic Resonance Imaging (MRI), including MR-Angiography (MRA), Breast MRI and MR-guided breast biopsy, diagnostic and screening Computed Tomography (CT), and Positron Emission Tomography (PET)
Computed Tomography ( C T )
CT (or CAT) scanners create cross-section pictures of the body, allowing physicians to see organs, tissue and bones in much greater detail than with conventional x-rays. Both of our CT scanners are helical (or spiral) multi-slice scanners that allow for CT Angiography, Heart Scoring, Lung Screening and Virtual Colonoscopy. Because screening CTs offer both pros and cons, the American College of Radiology has developed guidelines to help patients decide if screening CTs are appropriate for them. Call us at 894-6200 for a free copy of these guidelines.
Magnetic Resonance Imaging ( M R I )
As the name implies, MRIs are created using magnetic fields. The stronger the magnet, the better the image. It’s that simple. Conventional MRIs use magnets six times stronger than can be used in any “open” MRI system. Thus, physicians who want the best possible images prefer conventional MRI when at all feasible. We have two conventional MRI scanners. Our Short Bore scanner provides the most spacious patient area available without compromising magnet strength and image quality.
Positron Emission Tomography ( P E T )
Positron Emission Tomography (PET) is a powerful imaging technique that holds great promise in the diagnosis and treatment of many diseases, particularly cancer. A non-invasive test, PET scans accurately image the cellular function of the human body. A CT scan provides anatomical information such as location, size, and shape. Our scanner, a Philips Gemini GXL PET/CT, allows us to combine these two scanning technologies into a single PET/CT scan, which enables physicians to more accurately diagnose and identify cancer, heart disease and brain disorders, often earlier than other studies.